There are 2934 resources available
4204 - Assessment of Cardiotoxicity (CT) Associated with Doxorubicin (dox) in Patients (pts) with Advanced Soft Tissue Sarcoma (STS) in a Phase 3 Randomized Trial
Presenter: Robin Lewis Jones
Session: Proffered Paper – Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1872 - Long term follow-up (F/U) report of symptomatic cardiac events (SCEs) in 2,809 breast cancer (BC) patients (pts) treated with adjuvant trastuzumab (T) in real world (RW) practice
Presenter: Serena Di Cosimo
Session: Proffered Paper – Supportive and palliative care
Resources:
Abstract
Slides
Webcast
2609 - Overall survival (OS) in KATE2, a phase 2 study of programmed death ligand 1 (PD-L1) inhibitor atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC)
Presenter: Leisha Emens
Session: Proffered Paper - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
Discussion led by Chair
Presenter: Amanda Psyrri
Session: Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand?
Resources:
Slides
Webcast
Presentation by expert
Presenter: Sandro Pignata
Session: How to sequence treatment in platinum-sensitive relapsed ovarian cancer
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Robert Coleman
Session: How to sequence treatment in platinum-sensitive relapsed ovarian cancer
Resources:
Slides
Webcast
Presentation by expert
Presenter: Christoph Klein
Session: Metastasis, dormancy and late recurrence
Resources:
Slides
Webcast
Prediction of toxicity of immunotherapy
Presenter: Caroline Robert
Session: Precision medicine in melanoma therapy
Resources:
Slides
Webcast
Prediction of resistance to immunotherapy
Presenter: Antoni Ribas
Session: Precision medicine in melanoma therapy
Resources:
Slides
Webcast
Prediction of resistance to targeted therapies
Presenter: Christian Blank
Session: Precision medicine in melanoma therapy
Resources:
Slides
Webcast